Jordan P - Search Results

1

Emerging roles for WNK kinases in cancer.

Moniz S, Jordan P. Moniz S, et al. Among authors: jordan p. Cell Mol Life Sci. 2010 Apr;67(8):1265-76. doi: 10.1007/s00018-010-0261-6. Epub 2010 Jan 22. Cell Mol Life Sci. 2010. PMID: 20094755 Review.

2

Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors.

Jordan P, Brazåo R, Boavida MG, Gespach C, Chastre E. Jordan P, et al. Oncogene. 1999 Nov 18;18(48):6835-9. doi: 10.1038/sj.onc.1203233. Oncogene. 1999. PMID: 10597294

3

Molecular mechanisms involved in cisplatin cytotoxicity.

Jordan P, Carmo-Fonseca M. Jordan P, et al. Cell Mol Life Sci. 2000 Aug;57(8-9):1229-35. doi: 10.1007/pl00000762. Cell Mol Life Sci. 2000. PMID: 11028915 Review.

4

WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.

Veríssimo F, Jordan P. Veríssimo F, et al. Among authors: jordan p. Oncogene. 2001 Sep 6;20(39):5562-9. doi: 10.1038/sj.onc.1204726. Oncogene. 2001. PMID: 11571656

5

Three-way translocation involves MLL, MLLT3, and a novel cell cycle control gene, FLJ10374, in the pathogenesis of acute myeloid leukemia with t(9;11;19)(p22;q23;p13.3).

Vieira L, Sousa AC, Matos P, Marques B, Alaiz H, Ribeiro MJ, Braga P, da Silva MG, Jordan P. Vieira L, et al. Among authors: jordan p. Genes Chromosomes Cancer. 2006 May;45(5):455-69. doi: 10.1002/gcc.20311. Genes Chromosomes Cancer. 2006. PMID: 16450356

6

Protein kinase WNK3 increases cell survival in a caspase-3-dependent pathway.

Veríssimo F, Silva E, Morris JD, Pepperkok R, Jordan P. Veríssimo F, et al. Among authors: jordan p. Oncogene. 2006 Jul 13;25(30):4172-82. doi: 10.1038/sj.onc.1209449. Epub 2006 Feb 27. Oncogene. 2006. PMID: 16501604

7

Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells.

Matos P, Jordan P. Matos P, et al. Among authors: jordan p. J Biol Chem. 2006 May 12;281(19):13724-13732. doi: 10.1074/jbc.M513243200. Epub 2006 Mar 21. J Biol Chem. 2006. PMID: 16551621

8

Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2.

Moniz S, Veríssimo F, Matos P, Brazão R, Silva E, Kotelevets L, Chastre E, Gespach C, Jordan P. Moniz S, et al. Among authors: jordan p. Oncogene. 2007 Sep 6;26(41):6071-81. doi: 10.1038/sj.onc.1210706. Epub 2007 Jul 30. Oncogene. 2007. PMID: 17667937

9

WNK2 modulates MEK1 activity through the Rho GTPase pathway.

Moniz S, Matos P, Jordan P. Moniz S, et al. Among authors: jordan p. Cell Signal. 2008 Oct;20(10):1762-8. doi: 10.1016/j.cellsig.2008.06.002. Epub 2008 Jun 14. Cell Signal. 2008. PMID: 18593598

10

Increased Rac1b expression sustains colorectal tumor cell survival.

Matos P, Jordan P. Matos P, et al. Among authors: jordan p. Mol Cancer Res. 2008 Jul;6(7):1178-84. doi: 10.1158/1541-7786.MCR-08-0008. Mol Cancer Res. 2008. PMID: 18644982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results